<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Diffuse large B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (DLBLs) represent a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> collection of aggressive non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> that can arise either de novo or as a result of transformation from <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>, small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, or <z:hpo ids='HP_0002665'>lymphomas</z:hpo> of mucosa-associated lymphoid tissue </plain></SENT>
<SENT sid="1" pm="."><plain>A small percentage of DLBLs express the CD5 antigen </plain></SENT>
<SENT sid="2" pm="."><plain>The majority of these cases have evolved from a pre-existing low grade non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="C0349631" disease_type="Neoplastic Process" abbrv="">Richter's syndrome</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>However, we identified and characterized nine CD5-positive DLBLs in which the patients did not have a previous history or concomitant evidence of <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>, small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, or mucosa-associated lymphoid tissue-associated non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, suggesting that they arose de novo </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> nine cases expressed CD20 and monotypic immunoglobulin, <z:hpo ids='HP_0000001'>all</z:hpo> eight cases examined expressed CD19, CD22 and CD43, eight of the nine cases expressed HLA-DR, and two of eight cases expressed CD11c </plain></SENT>
<SENT sid="5" pm="."><plain>None of the cases expressed CD3, CD10, CD11b, CD21, CD23 or CD30 </plain></SENT>
<SENT sid="6" pm="."><plain>CD5 expression by these cells was found to be identical to that of CD5-positive B cell <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> by quantitative polymerase chain reaction analysis of CD5 <z:chebi fb="2" ids="33699">mRNA</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>These nine de novo CD5-positive DLBLs exhibited clonal immunoglobulin heavy and light chain gene rearrangements but lacked integration of the Epstein-Barr virus genome and structural alterations of the bcl-1, bcl-2, c-myc, H-ras, K-ras, and N-ras proto-oncogenes and the p53 <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene </plain></SENT>
<SENT sid="8" pm="."><plain>However, bcl-6 proto-oncogene rearrangement, which is involved in chromosome band 3q27 aberrations, was found in four cases (44.4%) </plain></SENT>
<SENT sid="9" pm="."><plain>This is comparable with the frequency of bcl-6 gene rearrangement in CD5-negative DLBL </plain></SENT>
<SENT sid="10" pm="."><plain>In contrast, bcl-6 gene rearrangement was absent in six cases of DLBL associated with <z:e sem="disease" ids="C0349631" disease_type="Neoplastic Process" abbrv="">Richter's syndrome</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>These findings suggest that de novo CD5-positive DLBLs are genotypically similar to CD5-negative DLBLs and may be pathogenetically distinct from the DLBLs associated with <z:e sem="disease" ids="C0349631" disease_type="Neoplastic Process" abbrv="">Richter's syndrome</z:e> </plain></SENT>
</text></document>